nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosphenytoin—ALB—Vismodegib—skin cancer	0.132	0.163	CbGbCtD
Fosphenytoin—ALB—Vemurafenib—skin cancer	0.104	0.129	CbGbCtD
Fosphenytoin—CYP2C8—Vismodegib—skin cancer	0.102	0.126	CbGbCtD
Fosphenytoin—CYP2C19—Vismodegib—skin cancer	0.0856	0.106	CbGbCtD
Fosphenytoin—CYP2C9—Vismodegib—skin cancer	0.0712	0.0881	CbGbCtD
Fosphenytoin—CYP3A4—Imiquimod—skin cancer	0.0597	0.0739	CbGbCtD
Fosphenytoin—CYP3A4—Temozolomide—skin cancer	0.0597	0.0739	CbGbCtD
Fosphenytoin—ALB—Fluorouracil—skin cancer	0.0469	0.058	CbGbCtD
Fosphenytoin—CYP3A4—Vismodegib—skin cancer	0.0414	0.0512	CbGbCtD
Fosphenytoin—CYP2C8—Fluorouracil—skin cancer	0.0362	0.0448	CbGbCtD
Fosphenytoin—CYP3A4—Vemurafenib—skin cancer	0.0327	0.0405	CbGbCtD
Fosphenytoin—CYP2C9—Fluorouracil—skin cancer	0.0253	0.0313	CbGbCtD
Fosphenytoin—CYP3A4—Docetaxel—skin cancer	0.0112	0.0139	CbGbCtD
Fosphenytoin—Cough—Imiquimod—skin cancer	0.000518	0.0027	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.000518	0.0027	CcSEcCtD
Fosphenytoin—Cardiac arrest—Fluorouracil—skin cancer	0.000518	0.0027	CcSEcCtD
Fosphenytoin—Convulsion—Imiquimod—skin cancer	0.000514	0.00268	CcSEcCtD
Fosphenytoin—Fluid retention—Docetaxel—skin cancer	0.000514	0.00268	CcSEcCtD
Fosphenytoin—Hypertension—Imiquimod—skin cancer	0.000513	0.00267	CcSEcCtD
Fosphenytoin—Ataxia—Fluorouracil—skin cancer	0.000512	0.00267	CcSEcCtD
Fosphenytoin—Dysphagia—Temozolomide—skin cancer	0.000511	0.00266	CcSEcCtD
Fosphenytoin—Pneumonia—Dactinomycin—skin cancer	0.000506	0.00264	CcSEcCtD
Fosphenytoin—Arthralgia—Imiquimod—skin cancer	0.000506	0.00263	CcSEcCtD
Fosphenytoin—Myalgia—Imiquimod—skin cancer	0.000506	0.00263	CcSEcCtD
Fosphenytoin—Discomfort—Imiquimod—skin cancer	0.000499	0.0026	CcSEcCtD
Fosphenytoin—Dry mouth—Imiquimod—skin cancer	0.000494	0.00258	CcSEcCtD
Fosphenytoin—Decreased appetite—Vemurafenib—skin cancer	0.000494	0.00257	CcSEcCtD
Fosphenytoin—Bronchitis—Temozolomide—skin cancer	0.000491	0.00256	CcSEcCtD
Fosphenytoin—Constipation—Vemurafenib—skin cancer	0.000486	0.00253	CcSEcCtD
Fosphenytoin—Hypoaesthesia—Bleomycin—skin cancer	0.000482	0.00251	CcSEcCtD
Fosphenytoin—Infection—Imiquimod—skin cancer	0.000481	0.00251	CcSEcCtD
Fosphenytoin—Muscular weakness—Fluorouracil—skin cancer	0.00048	0.0025	CcSEcCtD
Fosphenytoin—Dysuria—Temozolomide—skin cancer	0.000478	0.00249	CcSEcCtD
Fosphenytoin—Shock—Imiquimod—skin cancer	0.000477	0.00248	CcSEcCtD
Fosphenytoin—Tachycardia—Imiquimod—skin cancer	0.000473	0.00246	CcSEcCtD
Fosphenytoin—Dysphagia—Fluorouracil—skin cancer	0.000471	0.00245	CcSEcCtD
Fosphenytoin—Sepsis—Docetaxel—skin cancer	0.00047	0.00245	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Imiquimod—skin cancer	0.000468	0.00244	CcSEcCtD
Fosphenytoin—Photosensitivity reaction—Temozolomide—skin cancer	0.000466	0.00243	CcSEcCtD
Fosphenytoin—Anorexia—Imiquimod—skin cancer	0.000462	0.00241	CcSEcCtD
Fosphenytoin—Hyperglycaemia—Temozolomide—skin cancer	0.000461	0.0024	CcSEcCtD
Fosphenytoin—Pneumonia—Temozolomide—skin cancer	0.000458	0.00239	CcSEcCtD
Fosphenytoin—Thrombophlebitis—Docetaxel—skin cancer	0.000454	0.00237	CcSEcCtD
Fosphenytoin—Body temperature increased—Vemurafenib—skin cancer	0.000449	0.00234	CcSEcCtD
Fosphenytoin—Pharyngitis—Dactinomycin—skin cancer	0.000449	0.00234	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000442	0.0023	CcSEcCtD
Fosphenytoin—Deafness—Docetaxel—skin cancer	0.000439	0.00229	CcSEcCtD
Fosphenytoin—Insomnia—Imiquimod—skin cancer	0.000438	0.00228	CcSEcCtD
Fosphenytoin—Paraesthesia—Imiquimod—skin cancer	0.000435	0.00227	CcSEcCtD
Fosphenytoin—Chills—Bleomycin—skin cancer	0.000435	0.00227	CcSEcCtD
Fosphenytoin—Cardiac failure congestive—Docetaxel—skin cancer	0.000433	0.00226	CcSEcCtD
Fosphenytoin—Dyspnoea—Imiquimod—skin cancer	0.000432	0.00225	CcSEcCtD
Fosphenytoin—Somnolence—Imiquimod—skin cancer	0.000431	0.00224	CcSEcCtD
Fosphenytoin—Photosensitivity reaction—Fluorouracil—skin cancer	0.00043	0.00224	CcSEcCtD
Fosphenytoin—Sinusitis—Temozolomide—skin cancer	0.000427	0.00223	CcSEcCtD
Fosphenytoin—Dyspepsia—Imiquimod—skin cancer	0.000427	0.00222	CcSEcCtD
Fosphenytoin—Pneumonia—Fluorouracil—skin cancer	0.000422	0.0022	CcSEcCtD
Fosphenytoin—Decreased appetite—Imiquimod—skin cancer	0.000421	0.00219	CcSEcCtD
Fosphenytoin—Conjunctivitis—Fluorouracil—skin cancer	0.000408	0.00212	CcSEcCtD
Fosphenytoin—Asthenia—Vemurafenib—skin cancer	0.000408	0.00212	CcSEcCtD
Fosphenytoin—Hypoaesthesia—Temozolomide—skin cancer	0.000407	0.00212	CcSEcCtD
Fosphenytoin—Pharyngitis—Temozolomide—skin cancer	0.000406	0.00211	CcSEcCtD
Fosphenytoin—Chills—Dactinomycin—skin cancer	0.000406	0.00211	CcSEcCtD
Fosphenytoin—Pruritus—Vemurafenib—skin cancer	0.000402	0.00209	CcSEcCtD
Fosphenytoin—Feeling abnormal—Imiquimod—skin cancer	0.000399	0.00208	CcSEcCtD
Fosphenytoin—Epistaxis—Fluorouracil—skin cancer	0.000396	0.00206	CcSEcCtD
Fosphenytoin—Sinusitis—Fluorouracil—skin cancer	0.000394	0.00205	CcSEcCtD
Fosphenytoin—Gastrointestinal haemorrhage—Docetaxel—skin cancer	0.000393	0.00205	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Bleomycin—skin cancer	0.000391	0.00204	CcSEcCtD
Fosphenytoin—Anaemia—Bleomycin—skin cancer	0.00039	0.00203	CcSEcCtD
Fosphenytoin—Diarrhoea—Vemurafenib—skin cancer	0.000389	0.00203	CcSEcCtD
Fosphenytoin—Migraine—Docetaxel—skin cancer	0.000387	0.00202	CcSEcCtD
Fosphenytoin—Urticaria—Imiquimod—skin cancer	0.000385	0.00201	CcSEcCtD
Fosphenytoin—Body temperature increased—Imiquimod—skin cancer	0.000383	0.002	CcSEcCtD
Fosphenytoin—Tinnitus—Temozolomide—skin cancer	0.000381	0.00199	CcSEcCtD
Fosphenytoin—Malaise—Bleomycin—skin cancer	0.00038	0.00198	CcSEcCtD
Fosphenytoin—Leukopenia—Bleomycin—skin cancer	0.000378	0.00197	CcSEcCtD
Fosphenytoin—Rhinitis—Fluorouracil—skin cancer	0.000378	0.00197	CcSEcCtD
Fosphenytoin—Dizziness—Vemurafenib—skin cancer	0.000376	0.00196	CcSEcCtD
Fosphenytoin—Hypoaesthesia—Fluorouracil—skin cancer	0.000375	0.00195	CcSEcCtD
Fosphenytoin—Pharyngitis—Fluorouracil—skin cancer	0.000374	0.00195	CcSEcCtD
Fosphenytoin—Ataxia—Docetaxel—skin cancer	0.000369	0.00193	CcSEcCtD
Fosphenytoin—Cough—Bleomycin—skin cancer	0.000368	0.00192	CcSEcCtD
Fosphenytoin—Chills—Temozolomide—skin cancer	0.000367	0.00191	CcSEcCtD
Fosphenytoin—Dehydration—Docetaxel—skin cancer	0.000365	0.0019	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Dactinomycin—skin cancer	0.000365	0.0019	CcSEcCtD
Fosphenytoin—Anaemia—Dactinomycin—skin cancer	0.000364	0.00189	CcSEcCtD
Fosphenytoin—Liver function test abnormal—Docetaxel—skin cancer	0.000363	0.00189	CcSEcCtD
Fosphenytoin—Vomiting—Vemurafenib—skin cancer	0.000361	0.00188	CcSEcCtD
Fosphenytoin—Myalgia—Bleomycin—skin cancer	0.000359	0.00187	CcSEcCtD
Fosphenytoin—Orthostatic hypotension—Docetaxel—skin cancer	0.000359	0.00187	CcSEcCtD
Fosphenytoin—Rash—Vemurafenib—skin cancer	0.000358	0.00187	CcSEcCtD
Fosphenytoin—Dermatitis—Vemurafenib—skin cancer	0.000358	0.00187	CcSEcCtD
Fosphenytoin—Headache—Vemurafenib—skin cancer	0.000356	0.00185	CcSEcCtD
Fosphenytoin—Discomfort—Bleomycin—skin cancer	0.000355	0.00185	CcSEcCtD
Fosphenytoin—Malaise—Dactinomycin—skin cancer	0.000355	0.00185	CcSEcCtD
Fosphenytoin—Leukopenia—Dactinomycin—skin cancer	0.000352	0.00183	CcSEcCtD
Fosphenytoin—Dysgeusia—Temozolomide—skin cancer	0.000348	0.00182	CcSEcCtD
Fosphenytoin—Asthenia—Imiquimod—skin cancer	0.000348	0.00181	CcSEcCtD
Fosphenytoin—Confusional state—Bleomycin—skin cancer	0.000347	0.00181	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Bleomycin—skin cancer	0.000344	0.00179	CcSEcCtD
Fosphenytoin—Back pain—Temozolomide—skin cancer	0.000344	0.00179	CcSEcCtD
Fosphenytoin—Pruritus—Imiquimod—skin cancer	0.000343	0.00179	CcSEcCtD
Fosphenytoin—Infection—Bleomycin—skin cancer	0.000342	0.00178	CcSEcCtD
Fosphenytoin—Dysphagia—Docetaxel—skin cancer	0.00034	0.00177	CcSEcCtD
Fosphenytoin—Nausea—Vemurafenib—skin cancer	0.000338	0.00176	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Bleomycin—skin cancer	0.000337	0.00176	CcSEcCtD
Fosphenytoin—Myalgia—Dactinomycin—skin cancer	0.000335	0.00175	CcSEcCtD
Fosphenytoin—Tremor—Temozolomide—skin cancer	0.000333	0.00174	CcSEcCtD
Fosphenytoin—Diarrhoea—Imiquimod—skin cancer	0.000332	0.00173	CcSEcCtD
Fosphenytoin—Discomfort—Dactinomycin—skin cancer	0.000331	0.00172	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Temozolomide—skin cancer	0.00033	0.00172	CcSEcCtD
Fosphenytoin—Anaemia—Temozolomide—skin cancer	0.000329	0.00171	CcSEcCtD
Fosphenytoin—Anorexia—Bleomycin—skin cancer	0.000328	0.00171	CcSEcCtD
Fosphenytoin—Agitation—Temozolomide—skin cancer	0.000327	0.0017	CcSEcCtD
Fosphenytoin—Hypotension—Bleomycin—skin cancer	0.000322	0.00168	CcSEcCtD
Fosphenytoin—Malaise—Temozolomide—skin cancer	0.000321	0.00167	CcSEcCtD
Fosphenytoin—Dizziness—Imiquimod—skin cancer	0.00032	0.00167	CcSEcCtD
Fosphenytoin—Vertigo—Temozolomide—skin cancer	0.00032	0.00167	CcSEcCtD
Fosphenytoin—Infection—Dactinomycin—skin cancer	0.000319	0.00166	CcSEcCtD
Fosphenytoin—Leukopenia—Temozolomide—skin cancer	0.000319	0.00166	CcSEcCtD
Fosphenytoin—Palpitations—Temozolomide—skin cancer	0.000314	0.00164	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Dactinomycin—skin cancer	0.000314	0.00164	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000314	0.00163	CcSEcCtD
Fosphenytoin—Cough—Temozolomide—skin cancer	0.000311	0.00162	CcSEcCtD
Fosphenytoin—Paraesthesia—Bleomycin—skin cancer	0.000309	0.00161	CcSEcCtD
Fosphenytoin—Convulsion—Temozolomide—skin cancer	0.000308	0.00161	CcSEcCtD
Fosphenytoin—Vomiting—Imiquimod—skin cancer	0.000308	0.00161	CcSEcCtD
Fosphenytoin—Hypertension—Temozolomide—skin cancer	0.000307	0.0016	CcSEcCtD
Fosphenytoin—Dyspnoea—Bleomycin—skin cancer	0.000307	0.0016	CcSEcCtD
Fosphenytoin—Anorexia—Dactinomycin—skin cancer	0.000306	0.00159	CcSEcCtD
Fosphenytoin—Rash—Imiquimod—skin cancer	0.000306	0.00159	CcSEcCtD
Fosphenytoin—Dermatitis—Imiquimod—skin cancer	0.000305	0.00159	CcSEcCtD
Fosphenytoin—Pneumonia—Docetaxel—skin cancer	0.000305	0.00159	CcSEcCtD
Fosphenytoin—Headache—Imiquimod—skin cancer	0.000304	0.00158	CcSEcCtD
Fosphenytoin—Anaemia—Fluorouracil—skin cancer	0.000303	0.00158	CcSEcCtD
Fosphenytoin—Myalgia—Temozolomide—skin cancer	0.000303	0.00158	CcSEcCtD
Fosphenytoin—Arthralgia—Temozolomide—skin cancer	0.000303	0.00158	CcSEcCtD
Fosphenytoin—Discomfort—Temozolomide—skin cancer	0.000299	0.00156	CcSEcCtD
Fosphenytoin—Decreased appetite—Bleomycin—skin cancer	0.000299	0.00156	CcSEcCtD
Fosphenytoin—Renal failure—Docetaxel—skin cancer	0.000298	0.00155	CcSEcCtD
Fosphenytoin—Dry mouth—Temozolomide—skin cancer	0.000296	0.00154	CcSEcCtD
Fosphenytoin—Conjunctivitis—Docetaxel—skin cancer	0.000294	0.00153	CcSEcCtD
Fosphenytoin—Leukopenia—Fluorouracil—skin cancer	0.000293	0.00153	CcSEcCtD
Fosphenytoin—Confusional state—Temozolomide—skin cancer	0.000293	0.00153	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000293	0.00152	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Temozolomide—skin cancer	0.00029	0.00151	CcSEcCtD
Fosphenytoin—Infection—Temozolomide—skin cancer	0.000289	0.0015	CcSEcCtD
Fosphenytoin—Nausea—Imiquimod—skin cancer	0.000288	0.0015	CcSEcCtD
Fosphenytoin—Epistaxis—Docetaxel—skin cancer	0.000286	0.00149	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Temozolomide—skin cancer	0.000284	0.00148	CcSEcCtD
Fosphenytoin—Convulsion—Fluorouracil—skin cancer	0.000284	0.00148	CcSEcCtD
Fosphenytoin—Feeling abnormal—Bleomycin—skin cancer	0.000284	0.00148	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Temozolomide—skin cancer	0.000281	0.00146	CcSEcCtD
Fosphenytoin—Myalgia—Fluorouracil—skin cancer	0.000279	0.00145	CcSEcCtD
Fosphenytoin—Decreased appetite—Dactinomycin—skin cancer	0.000279	0.00145	CcSEcCtD
Fosphenytoin—Anorexia—Temozolomide—skin cancer	0.000277	0.00144	CcSEcCtD
Fosphenytoin—Discomfort—Fluorouracil—skin cancer	0.000276	0.00144	CcSEcCtD
Fosphenytoin—Urticaria—Bleomycin—skin cancer	0.000274	0.00143	CcSEcCtD
Fosphenytoin—Rhinitis—Docetaxel—skin cancer	0.000273	0.00142	CcSEcCtD
Fosphenytoin—Body temperature increased—Bleomycin—skin cancer	0.000272	0.00142	CcSEcCtD
Fosphenytoin—Hypoaesthesia—Docetaxel—skin cancer	0.00027	0.00141	CcSEcCtD
Fosphenytoin—Confusional state—Fluorouracil—skin cancer	0.00027	0.00141	CcSEcCtD
Fosphenytoin—Pharyngitis—Docetaxel—skin cancer	0.00027	0.00141	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Fluorouracil—skin cancer	0.000268	0.00139	CcSEcCtD
Fosphenytoin—Infection—Fluorouracil—skin cancer	0.000266	0.00139	CcSEcCtD
Fosphenytoin—Feeling abnormal—Dactinomycin—skin cancer	0.000265	0.00138	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000265	0.00138	CcSEcCtD
Fosphenytoin—Insomnia—Temozolomide—skin cancer	0.000263	0.00137	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Fluorouracil—skin cancer	0.000262	0.00137	CcSEcCtD
Fosphenytoin—Tachycardia—Fluorouracil—skin cancer	0.000261	0.00136	CcSEcCtD
Fosphenytoin—Paraesthesia—Temozolomide—skin cancer	0.000261	0.00136	CcSEcCtD
Fosphenytoin—Dyspnoea—Temozolomide—skin cancer	0.000259	0.00135	CcSEcCtD
Fosphenytoin—Somnolence—Temozolomide—skin cancer	0.000258	0.00135	CcSEcCtD
Fosphenytoin—Dyspepsia—Temozolomide—skin cancer	0.000256	0.00133	CcSEcCtD
Fosphenytoin—Anorexia—Fluorouracil—skin cancer	0.000255	0.00133	CcSEcCtD
Fosphenytoin—Body temperature increased—Dactinomycin—skin cancer	0.000254	0.00132	CcSEcCtD
Fosphenytoin—Decreased appetite—Temozolomide—skin cancer	0.000252	0.00132	CcSEcCtD
Fosphenytoin—Hypotension—Fluorouracil—skin cancer	0.00025	0.0013	CcSEcCtD
Fosphenytoin—Constipation—Temozolomide—skin cancer	0.000248	0.00129	CcSEcCtD
Fosphenytoin—Asthenia—Bleomycin—skin cancer	0.000247	0.00129	CcSEcCtD
Fosphenytoin—Chills—Docetaxel—skin cancer	0.000244	0.00127	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000244	0.00127	CcSEcCtD
Fosphenytoin—Pruritus—Bleomycin—skin cancer	0.000244	0.00127	CcSEcCtD
Fosphenytoin—Insomnia—Fluorouracil—skin cancer	0.000242	0.00126	CcSEcCtD
Fosphenytoin—Paraesthesia—Fluorouracil—skin cancer	0.00024	0.00125	CcSEcCtD
Fosphenytoin—Feeling abnormal—Temozolomide—skin cancer	0.000239	0.00125	CcSEcCtD
Fosphenytoin—Dyspnoea—Fluorouracil—skin cancer	0.000239	0.00124	CcSEcCtD
Fosphenytoin—Somnolence—Fluorouracil—skin cancer	0.000238	0.00124	CcSEcCtD
Fosphenytoin—Dyspepsia—Fluorouracil—skin cancer	0.000236	0.00123	CcSEcCtD
Fosphenytoin—Decreased appetite—Fluorouracil—skin cancer	0.000233	0.00121	CcSEcCtD
Fosphenytoin—Dysgeusia—Docetaxel—skin cancer	0.000232	0.00121	CcSEcCtD
Fosphenytoin—Urticaria—Temozolomide—skin cancer	0.000231	0.0012	CcSEcCtD
Fosphenytoin—Asthenia—Dactinomycin—skin cancer	0.00023	0.0012	CcSEcCtD
Fosphenytoin—Body temperature increased—Temozolomide—skin cancer	0.00023	0.0012	CcSEcCtD
Fosphenytoin—Back pain—Docetaxel—skin cancer	0.000229	0.00119	CcSEcCtD
Fosphenytoin—Muscle spasms—Docetaxel—skin cancer	0.000228	0.00119	CcSEcCtD
Fosphenytoin—Feeling abnormal—Fluorouracil—skin cancer	0.000221	0.00115	CcSEcCtD
Fosphenytoin—Diarrhoea—Dactinomycin—skin cancer	0.00022	0.00114	CcSEcCtD
Fosphenytoin—Vomiting—Bleomycin—skin cancer	0.000219	0.00114	CcSEcCtD
Fosphenytoin—Anaemia—Docetaxel—skin cancer	0.000219	0.00114	CcSEcCtD
Fosphenytoin—Rash—Bleomycin—skin cancer	0.000217	0.00113	CcSEcCtD
Fosphenytoin—Dermatitis—Bleomycin—skin cancer	0.000217	0.00113	CcSEcCtD
Fosphenytoin—Urticaria—Fluorouracil—skin cancer	0.000213	0.00111	CcSEcCtD
Fosphenytoin—Syncope—Docetaxel—skin cancer	0.000212	0.00111	CcSEcCtD
Fosphenytoin—Leukopenia—Docetaxel—skin cancer	0.000212	0.0011	CcSEcCtD
Fosphenytoin—Body temperature increased—Fluorouracil—skin cancer	0.000212	0.0011	CcSEcCtD
Fosphenytoin—Palpitations—Docetaxel—skin cancer	0.000209	0.00109	CcSEcCtD
Fosphenytoin—Asthenia—Temozolomide—skin cancer	0.000208	0.00109	CcSEcCtD
Fosphenytoin—Loss of consciousness—Docetaxel—skin cancer	0.000208	0.00108	CcSEcCtD
Fosphenytoin—Cough—Docetaxel—skin cancer	0.000206	0.00108	CcSEcCtD
Fosphenytoin—Pruritus—Temozolomide—skin cancer	0.000205	0.00107	CcSEcCtD
Fosphenytoin—Convulsion—Docetaxel—skin cancer	0.000205	0.00107	CcSEcCtD
Fosphenytoin—Nausea—Bleomycin—skin cancer	0.000204	0.00107	CcSEcCtD
Fosphenytoin—Hypertension—Docetaxel—skin cancer	0.000204	0.00106	CcSEcCtD
Fosphenytoin—Vomiting—Dactinomycin—skin cancer	0.000204	0.00106	CcSEcCtD
Fosphenytoin—Rash—Dactinomycin—skin cancer	0.000202	0.00105	CcSEcCtD
Fosphenytoin—Arthralgia—Docetaxel—skin cancer	0.000201	0.00105	CcSEcCtD
Fosphenytoin—Myalgia—Docetaxel—skin cancer	0.000201	0.00105	CcSEcCtD
Fosphenytoin—Diarrhoea—Temozolomide—skin cancer	0.000199	0.00104	CcSEcCtD
Fosphenytoin—Dry mouth—Docetaxel—skin cancer	0.000197	0.00103	CcSEcCtD
Fosphenytoin—Confusional state—Docetaxel—skin cancer	0.000195	0.00101	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Docetaxel—skin cancer	0.000193	0.00101	CcSEcCtD
Fosphenytoin—Dizziness—Temozolomide—skin cancer	0.000192	0.001	CcSEcCtD
Fosphenytoin—Infection—Docetaxel—skin cancer	0.000192	0.001	CcSEcCtD
Fosphenytoin—Nausea—Dactinomycin—skin cancer	0.000191	0.000994	CcSEcCtD
Fosphenytoin—Shock—Docetaxel—skin cancer	0.00019	0.00099	CcSEcCtD
Fosphenytoin—Pruritus—Fluorouracil—skin cancer	0.000189	0.000986	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Docetaxel—skin cancer	0.000189	0.000985	CcSEcCtD
Fosphenytoin—Tachycardia—Docetaxel—skin cancer	0.000188	0.000982	CcSEcCtD
Fosphenytoin—Vomiting—Temozolomide—skin cancer	0.000185	0.000962	CcSEcCtD
Fosphenytoin—Anorexia—Docetaxel—skin cancer	0.000184	0.000959	CcSEcCtD
Fosphenytoin—Rash—Temozolomide—skin cancer	0.000183	0.000954	CcSEcCtD
Fosphenytoin—Diarrhoea—Fluorouracil—skin cancer	0.000183	0.000954	CcSEcCtD
Fosphenytoin—Dermatitis—Temozolomide—skin cancer	0.000183	0.000953	CcSEcCtD
Fosphenytoin—Headache—Temozolomide—skin cancer	0.000182	0.000948	CcSEcCtD
Fosphenytoin—Hypotension—Docetaxel—skin cancer	0.00018	0.00094	CcSEcCtD
Fosphenytoin—Dizziness—Fluorouracil—skin cancer	0.000177	0.000922	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000176	0.000917	CcSEcCtD
Fosphenytoin—Insomnia—Docetaxel—skin cancer	0.000175	0.00091	CcSEcCtD
Fosphenytoin—Paraesthesia—Docetaxel—skin cancer	0.000173	0.000904	CcSEcCtD
Fosphenytoin—Nausea—Temozolomide—skin cancer	0.000173	0.000899	CcSEcCtD
Fosphenytoin—Dyspnoea—Docetaxel—skin cancer	0.000172	0.000897	CcSEcCtD
Fosphenytoin—Somnolence—Docetaxel—skin cancer	0.000172	0.000895	CcSEcCtD
Fosphenytoin—Vomiting—Fluorouracil—skin cancer	0.00017	0.000886	CcSEcCtD
Fosphenytoin—Dyspepsia—Docetaxel—skin cancer	0.00017	0.000886	CcSEcCtD
Fosphenytoin—Rash—Fluorouracil—skin cancer	0.000169	0.000879	CcSEcCtD
Fosphenytoin—Dermatitis—Fluorouracil—skin cancer	0.000169	0.000878	CcSEcCtD
Fosphenytoin—Decreased appetite—Docetaxel—skin cancer	0.000168	0.000875	CcSEcCtD
Fosphenytoin—Headache—Fluorouracil—skin cancer	0.000168	0.000873	CcSEcCtD
Fosphenytoin—Constipation—Docetaxel—skin cancer	0.000165	0.000861	CcSEcCtD
Fosphenytoin—Feeling abnormal—Docetaxel—skin cancer	0.000159	0.000829	CcSEcCtD
Fosphenytoin—Nausea—Fluorouracil—skin cancer	0.000159	0.000828	CcSEcCtD
Fosphenytoin—Body temperature increased—Docetaxel—skin cancer	0.000153	0.000795	CcSEcCtD
Fosphenytoin—Asthenia—Docetaxel—skin cancer	0.000139	0.000722	CcSEcCtD
Fosphenytoin—Pruritus—Docetaxel—skin cancer	0.000137	0.000712	CcSEcCtD
Fosphenytoin—Diarrhoea—Docetaxel—skin cancer	0.000132	0.000688	CcSEcCtD
Fosphenytoin—Dizziness—Docetaxel—skin cancer	0.000128	0.000665	CcSEcCtD
Fosphenytoin—Vomiting—Docetaxel—skin cancer	0.000123	0.00064	CcSEcCtD
Fosphenytoin—Rash—Docetaxel—skin cancer	0.000122	0.000634	CcSEcCtD
Fosphenytoin—Dermatitis—Docetaxel—skin cancer	0.000122	0.000634	CcSEcCtD
Fosphenytoin—Headache—Docetaxel—skin cancer	0.000121	0.00063	CcSEcCtD
Fosphenytoin—Nausea—Docetaxel—skin cancer	0.000115	0.000598	CcSEcCtD
